Functional Neuromodulation

Functional Neuromodulation

Medical Devices, 200 S 6th St, Minneapolis, Minnesota, 55402, United States, 1-10 Employees

fxneuromod.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 86********

Who is FUNCTIONAL NEUROMODULATION

Functional Neuromodulation Ltd. is investigating the use of deep brain stimulation of the fornix (DBS-f) to drive neural activity and modulate the brains memory circuit. The company compl...

Read More

map
  • 200 S 6th St, Minneapolis, Minnesota, 55402, United States Headquarters: 200 S 6th St, Minneapolis, Minnesota, 55402, United States
  • 2011 Date Founded: 2011
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 2834 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from FUNCTIONAL NEUROMODULATION

Functional Neuromodulation Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Functional Neuromodulation

Answer: Functional Neuromodulation's headquarters are located at 200 S 6th St, Minneapolis, Minnesota, 55402, United States

Answer: Functional Neuromodulation's phone number is 86********

Answer: Functional Neuromodulation's official website is https://fxneuromod.com

Answer: Functional Neuromodulation's revenue is $5 Million to $10 Million

Answer: Functional Neuromodulation's SIC: 2834

Answer: Functional Neuromodulation's NAICS: 561110

Answer: Functional Neuromodulation has 1-10 employees

Answer: Functional Neuromodulation is in Medical Devices

Answer: Functional Neuromodulation contact info: Phone number: 86******** Website: https://fxneuromod.com

Answer: Functional Neuromodulation Ltd. is investigating the use of deep brain stimulation of the fornix (DBS-f) to drive neural activity and modulate the brains memory circuit. The company completed a Phase II multi-center clinical trial of DBS-f in 42 patients with mild probable Alzheimers. Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with mild Alzheimers disease. CAUTION Investigational device. Limited by Federal law to investigational use

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access